VYYRF (Voyageur Pharmaceuticals) 12-1 Month Momentum %: -22.18% (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VYYRF Voyageur Pharmaceuticals Ltd VYYRF
28 GF Score
Price $0.12
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals 12-1 Month Momentum %?

Voyageur Pharmaceuticals VYYRF +1.69% 28 12-1 Month Momentum % is -22.18% as of Aug. 26, 2026. GuruFocus rates VYYRF with a GF Score™ of 28/100. The stock has 5 warning signs investors should review. Among 1,016 Drug Manufacturers companies, Voyageur Pharmaceuticals ranks worse than 55.12% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-26), Voyageur Pharmaceuticals's 12-1 Month Momentum % is -22.18%.

The industry rank for Voyageur Pharmaceuticals's 12-1 Month Momentum % or its related term are showing as below:

VYYRF's 12-1 Month Momentum % is ranked worse than
55.12% of 1016 companies
in the Drug Manufacturers industry
Industry Median: -17.565 vs VYYRF: -22.18

Voyageur Pharmaceuticals  (OTCPK:VYYRF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Voyageur Pharmaceuticals 12-1 Month Momentum % Related Terms

VYYRF vs ZTS: 12-1 Month Momentum % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Voyageur Pharmaceuticals 12-1 Month Momentum % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's 12-1 Month Momentum % falls into.


VYYRF
28GF Score
Voyageur Pharmaceuticals Ltd VYYRF
12-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals  (OTCPK:VYYRF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of -22.18% mean?
Voyageur Pharmaceuticals (VYYRF) has a 12-1 Month Momentum % of -22.18% as of Aug. 26, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Voyageur Pharmaceuticals and its competitors. According to the industry distribution chart, Voyageur Pharmaceuticals ranks #560 out of 1016 companies in the Drug Manufacturers industry, placing it in the top 55.1%.
Is Voyageur Pharmaceuticals' 12-1 Month Momentum % too high?
Voyageur Pharmaceuticals' current 12-1 Month Momentum % is -22.18%. Based on the distribution chart, Voyageur Pharmaceuticals ranks #560 out of 1016 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Voyageur Pharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' 12-1 Month Momentum % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Voyageur Pharmaceuticals ranks #560 out of 1016 companies for 12-1 Month Momentum %. This places Voyageur Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Drug Manufacturers company?
A good 12-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Voyageur Pharmaceuticals and its competitors. Voyageur Pharmaceuticals's current 12-1 Month Momentum % is -22.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current 12-1 Month Momentum % of -22.18%. The current 12-1 Month Momentum % is -22.18%. Voyageur Pharmaceuticals' overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current 12-1 Month Momentum % is -22.18% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
28GF Score

Get the complete analysis for VYYRF

12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price